Acorah Software Products - Accounts Production 19.3.550 false true false true No description of principal activity 1 August 2024 31 July 2025 31 July 2025 15014930 Dr Hesham Alnahal iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15014930 2024-07-31 15014930 2025-07-31 15014930 2024-08-01 2025-07-31 15014930 frs-core:CurrentFinancialInstruments 2025-07-31 15014930 frs-bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 15014930 frs-bus:FilletedAccounts 2024-08-01 2025-07-31 15014930 frs-bus:Micro-entities 2024-08-01 2025-07-31 15014930 frs-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 15014930 frs-bus:Director1 2024-08-01 2025-07-31
Registered number: 15014930
Alna-Health Ltd
Financial Statements
For The Year Ended 31 July 2025
Chartax Accountancy Ltd
Chartax Suite 103
Island Business Centre
London
SE18 6PF
Balance Sheet
Registered number: 15014930
2025
£
Fixed assets 1,378
Current assets 13,505
Creditors: Amounts Falling Due Within One Year (693 )
NET CURRENT ASSETS 12,812
TOTAL ASSETS LESS CURRENT LIABILITIES 14,190
Accruals and deferred income (890 )
NET ASSETS 13,300
CAPITAL AND RESERVES 13,300

Notes

1. General Information
Alna-Health Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15014930 . The registered office is 51 Elvington, King's Lynn, PE30 4TB.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Hesham Alnahal
Director
31st July 2026